5mg min 0.5mg dut - temple regrowth but ravaged crown? 28M
    Progress Pictures 3/6/2026

    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    šŸ’Š Minoxidil (oral) 5mg
    šŸ’Š Dutasteride (oral) 0.5mg
    the tone is šŸ˜€ positive with temple regrowth, crown thinning results.

    Other terms

    A 28-year-old male is experiencing temple regrowth but crown thinning while using 5mg minoxidil and 0.5mg dutasteride. The shedding phase is seen as a positive sign of treatment effectiveness, with expectations of noticeable improvements around 6 to 12 months.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Telogen Effluvium: Comprehensive Overview and Treatment

      research Telogen Effluvium

      3 citations , February 2008 in “Basic and clinical dermatology”
      Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.
      Androgenetic Alopecia: A Review and Emerging Treatments

      research Androgenetic Alopecia: a Review and Emerging Treatments

      1 citations , July 2017 in “Clinical research in dermatology”
      This review covers the pathogenesis, diagnosis, and potential new treatments for androgenetic alopecia but reports no new clinical findings, highlighting an ongoing need for effective therapies.
      Interventions for Female Pattern Hair Loss

      research Interventions for female pattern hair loss

      21 citations , May 2016 in “The Cochrane library”
      This review found that while topical minoxidil is effective for treating female pattern hair loss, finasteride showed no more effectiveness than placebo, and low-level laser therapy increased hair count but with inconsistent results.
      A Review on Herbal Drugs Used for Hair Growth Promotion

      research A Review on Herbal Drugs Used For Hair Growth Promotion

      May 2026 in “International Journal of Drug Delivery Technology”
      This source describes how androgenic alopecia, or pattern hair loss, affects about 70% of men and is linked to factors like stress, hormonal imbalances, and lifestyle issues, which can also impact psychological well-being and potentially contribute to severe health conditions such as heart disease.
      Nonscarring Alopecias: Overview and Treatment

      research Nonscarring Alopecias

      July 2012 in “Springer eBooks”
      The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.